Filing summary
Registrant: Better Choice Company Inc. (NYSE American: BTTR). The request metadata names SRX Global Inc., but the supplied filing is Better Choice Company Inc.’s Form 10-K. Reporting period: fiscal year ended December 31, 2023; the filing is an annual report, not a quarterly report. Financial statements are audited and prepared under U.S. GAAP. The auditor issued an unqualified opinion, while highlighting substantial doubt about the Company’s ability to continue as a going concern.
Key financial results
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Net sales | $38.6 million | $54.7 million | Down 29% |
| Gross profit / margin | $11.8 million / 31% | $15.3 million / 28% | Profit down 23%; margin up 3 percentage points |
| Operating loss | $21.2 million | $38.8 million | Loss narrowed |
| Net loss | $22.8 million | $39.3 million | Loss narrowed |
| Operating cash flow | $0.1 million provided | $20.6 million used | Improved substantially |
| Cash and restricted cash at year-end | $4.5 million | $9.5 million | Down $5.0 million |
| Debt reported on balance sheet | $4.6 million | $11.4 million | Down $6.8 million |
Gross margin improved despite lower sales, with management citing lower average product cost and pricing actions; excess-inventory discounts reduced gross profit. Selling, general and administrative expense was $24.4 million, down 31%. 2023 included an $8.5 million non-cash impairment of intangible assets; 2022 included an $18.6 million goodwill impairment. Interest expense rose to $1.4 million from $0.6 million. No meaningful profitability was achieved, and accumulated deficit was $321.3 million at year-end.
Business and material changes
- The Company sells premium pet food and wellness products under the Halo brand through e-commerce, brick-and-mortar, direct-to-consumer (DTC), and international channels.
- International sales fell to $13.7 million from $21.9 million; management attributed the decline largely to inventory normalization in Asia and macroeconomic conditions. China accounted for $11.0 million of 2023 net sales.
- Supply disruptions and production delays at the dry-kibble manufacturer caused out-of-stocks, weaker fulfillment, and lower sales, particularly for Halo Elevate and brick-and-mortar customers. Transitioning dry-kibble production back to Alphia also delayed some international registrations and orders.
- In December 2023, the Company exited Petco stores (while remaining on Petco.com) and Pet Supplies Plus. It planned to exit DTC in Q2 2024 to improve profitability and shifted toward a digital-first strategy.
- Revenue concentration remains notable: three customers represented 62% of gross sales in 2023; two e-commerce customers and one China distributor each exceeded 10% of net sales. Two suppliers represented 64% of inventory purchases.
Liquidity, debt, and outlook
- Management says recurring losses and expected near-term cash consumption raise substantial doubt about the Company’s ability to continue as a going concern. It says additional capital or financing, lender waivers or amendments, cost savings, or other strategic actions may be needed; there is no assurance these will be available or successful.
- The Alphia term loan carries 10% annual interest, compounded quarterly, and matures June 21, 2026. The Company reported covenant noncompliance at December 31, 2023; the lender may call the debt. Disclosed covenants include minimum liquidity of $3.0 million, minimum EBITDA of negative $4.5 million, and a maximum marketing-spend ratio of 30%.
- The Wintrust receivables facility had $1.7 million outstanding at year-end, with an interest rate of 11% then. The Company repaid its prior $13.5 million Wintrust credit facility in June 2023.
- There is an apparent debt presentation issue to reconcile: the balance sheet reports $2.9 million net term loan and $1.7 million line of credit, both current; the debt note describes $5.0 million principal plus PIK interest before discount, while the maturity schedule lists $5.3 million due in 2024 despite the stated 2026 Alphia maturity.
- Management’s operating actions include margin improvement initiatives, supplier consolidation, pricing and ingredient-profile changes, new-product innovation, and working-capital discipline. No quantified revenue, earnings, or cash-flow guidance is provided.
Risks, contingencies, and unusual items
- Disclosure controls and internal control over financial reporting were deemed ineffective at year-end due to material weaknesses involving a 2023 email compromise and IT controls, complex accounting and impairment assessments, and revenue-recognition controls. Management described remediation plans; effectiveness has not yet been established. The auditor did not attest to internal controls.
- The filing reports a 2023 cybersecurity incident involving an email account lacking multifactor authentication. Management said past threats and breach attempts had not materially affected the business, but the incident contributed to a disclosed material weakness.
- The Company received a NYSE American noncompliance notice in 2023 and faced potential delisting if it failed to cure the issue. The filing does not establish the ultimate outcome.
- Subsequent events include a February 2024 acquisition of Aimia Pet Healthco for 45,629 shares; the accounting evaluation was incomplete. In March 2024, the Company initiated legal action to enforce an Alphia right-of-first-refusal option; the outcome and business impact were uncertain.
- A 1-for-44 reverse stock split became effective March 20, 2024. The filing also identifies risks from customer and supplier concentration, international and China exposure, product safety and recalls, competition, and access to financing.
Important facts for investors to verify
- Confirm the issuer identity: the provided metadata says SRX Global Inc., whereas the filing identifies Better Choice Company Inc. (BTTR).
- Review current covenant status, any Alphia waiver or default action, and the amount and classification of debt after the year-end reporting date.
- Reconcile the debt note, balance-sheet amounts, and 2024 maturity schedule, and assess available liquidity against obligations.
- Check the status of the NYSE American listing notice, the going-concern plan, and the Company’s ability to raise capital or obtain lender support.
- Assess whether supply has stabilized, whether channel exits improve profitability, and how customer and China concentration affect future sales and cash generation.
- Track remediation and testing of the disclosed material weaknesses, and the outcomes of the Aimia acquisition accounting and Alphia ROFR litigation.